{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:09:38Z","timestamp":1791994178696,"version":"4.4.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T00:00:00Z","timestamp":1550188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T00:00:00Z","timestamp":1550188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA \u2013 60047689"],"award-info":[{"award-number":["CA \u2013 60047689"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA \u2013 60047689"],"award-info":[{"award-number":["CA \u2013 60047689"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32-GM086252"],"award-info":[{"award-number":["T32-GM086252"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Fhit protein is lost in cancers of most, perhaps all, cancer types; when restored, it can induce apoptosis and suppress tumorigenicity, as shown in vitro and in mouse tumor models in vivo. Following protein cross-linking and proteomics analyses, we characterized a Fhit protein complex involved in triggering Fhit-mediated apoptosis. The complex includes the heat-shock chaperonin pair, HSP60\/10, which is likely involved in importing Fhit into the mitochondria, where it interacts with ferredoxin reductase, responsible for transferring electrons from NADPH to cytochrome P450 via ferredoxin, in electron transport chain complex III. Overexpression of Fhit protein in Fhit-deficient cancer cells modulates the production of intracellular reactive oxygen species, causing increased ROS, following peroxide treatment, with subsequent increased apoptosis of lung cancer cells under oxidative stress conditions; conversely, Fhit-negative cells escape ROS overproduction and ROS-induced apoptosis, likely carrying oxidative damage. Thus, characterization of Fhit-interacting proteins has identified direct effectors of a Fhit-mediated apoptotic signal pathway that is lost in many cancers. This is of translational interest considering the very recent emphasis in a number of high-profile publications, concerning the role of oxidative phosphorylation in the treatment of human cancers, and especially cancer stem cells that rely upon oxidative phosphorylation for survival. Additionally, we have shown that cells from a Fhit-deficient lung cancer cell line, are sensitive to killing by exposure to atovaquone, thought to act as a selective oxidative phosphorylation inhibitor by targeting the CoQ10 dependence of the mitochondrial complex III, while the Fhit-expressing sister clone is resistant to this treatment.<\/jats:p>","DOI":"10.1038\/s41419-019-1414-7","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T04:04:13Z","timestamp":1550203453000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Fhit\u2013Fdxr interaction in the mitochondria: modulation of reactive oxygen species generation and apoptosis in cancer cells"],"prefix":"10.1038","volume":"10","author":[{"given":"Teresa","family":"Druck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas G.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongju","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Trapasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Pichiorri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Gaspari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami I.","family":"Aqeilan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Gaudio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Iuliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Raso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"Huebner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo M.","family":"Croce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,15]]},"reference":[{"key":"1414_CR1","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0092-8674(00)81034-X","volume":"84","author":"M Ohta","year":"1996","unstructured":"Ohta, M. et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84, 587\u2013597 (1996).","journal-title":"Cell"},{"key":"1414_CR2","doi-asserted-by":"publisher","first-page":"14988","DOI":"10.1073\/pnas.2336256100","volume":"100","author":"A Matsuyama","year":"2003","unstructured":"Matsuyama, A. et al. Fragile site orthologs FHIT\/FRA3B and Fhit\/Fra14A2: evolutionarily conserved but highly recombinogenic. Proc. Natl. Acad. Sci. USA 100, 14988\u201314993 (2003).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1414_CR3","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1159\/000455753","volume":"150","author":"JR Karras","year":"2016","unstructured":"Karras, J. R., Schrock, M. S., Batar, B. & Huebner, K. Fragile genes that are frequently altered in cancer: players not passengers. Cytogenet. Genome Res. 150, 208\u2013216 (2016).","journal-title":"Cytogenet. Genome Res."},{"key":"1414_CR4","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1007\/s00018-014-1722-0","volume":"71","author":"CE Waters","year":"2014","unstructured":"Waters, C. E., Saldivar, J. C., Hosseini, S. A. & Huebner, K. The FHIT gene product: tumor suppressor and genome \u201ccaretaker\u201d. Cell. Mol. Life Sci. 71, 4577\u20134587 (2014).","journal-title":"Cell. Mol. Life Sci."},{"key":"1414_CR5","doi-asserted-by":"publisher","first-page":"102199","DOI":"10.18632\/oncotarget.22321","volume":"8","author":"S Volinia","year":"2017","unstructured":"Volinia, S., Druck, T., Paisie, C. A., Schrock, M. S. & Huebner, K. The ubiquitous \u2018cancer mutational signature\u2019 5 occurs specifically in cancers with deleted FHIT alleles. Oncotarget 8, 102199\u2013102211 (2017).","journal-title":"Oncotarget"},{"key":"1414_CR6","doi-asserted-by":"publisher","first-page":"4742","DOI":"10.1073\/pnas.080063497","volume":"97","author":"LY Fong","year":"2000","unstructured":"Fong, L. Y. et al. Muir-Torre-like syndrome in Fhit-deficient mice. Proc. Natl. Acad. Sci. USA 97, 4742\u20134747 (2000).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1414_CR7","doi-asserted-by":"publisher","first-page":"10250","DOI":"10.1073\/pnas.191345898","volume":"98","author":"N Zanesi","year":"2001","unstructured":"Zanesi, N. et al. The tumor spectrum in FHIT-deficient mice. Proc. Natl. Acad. Sci. USA 98, 10250\u201310255 (2001).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1414_CR8","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1073\/pnas.061020098","volume":"98","author":"KR Dumon","year":"2001","unstructured":"Dumon, K. R. et al. FHIT gene therapy prevents tumor development in Fhit-deficient mice. Proc. Natl. Acad. Sci. USA 98, 3346\u20133351 (2001).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1414_CR9","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1096\/fj.03-0241fje","volume":"17","author":"H Ishii","year":"2003","unstructured":"Ishii, H. et al. Regression of upper gastric cancer in mice by FHIT gene delivery. FASEB J. 17, 1768\u20131770 (2003).","journal-title":"FASEB J."},{"key":"1414_CR10","doi-asserted-by":"crossref","unstructured":"Siprashvili, Z.et al. Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc. Natl. Acad. Sci. USA 94, 13771\u201313776 (1997).","DOI":"10.1073\/pnas.94.25.13771"},{"key":"1414_CR11","first-page":"3333","volume":"59","author":"L Ji","year":"1999","unstructured":"Ji, L. et al. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression. Cancer Res. 59, 3333\u20133339 (1999).","journal-title":"Cancer Res."},{"key":"1414_CR12","first-page":"1578","volume":"61","author":"H Ishii","year":"2001","unstructured":"Ishii, H. et al. Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells. Cancer Res. 61, 1578\u20131584 (2001).","journal-title":"Cancer Res."},{"key":"1414_CR13","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1073\/pnas.062030799","volume":"99","author":"L Roz","year":"2002","unstructured":"Roz, L., Gramegna, M., Ishii, H., Croce, C. M. & Sozzi, G. Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines. Proc. Natl. Acad. Sci. USA 99, 3615\u20133620 (2002).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1414_CR14","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1073\/pnas.0437915100","volume":"100","author":"F Trapasso","year":"2003","unstructured":"Trapasso, F. et al. Designed FHIT alleles establish that Fhit-induced apoptosis in cancer cells is limited by substrate binding. Proc. Natl. Acad. Sci. USA 100, 1592\u20131597 (2003).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"1414_CR15","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/nature03485","volume":"434","author":"VG Gorgoulis","year":"2005","unstructured":"Gorgoulis, V. G. et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434, 907\u2013913 (2005).","journal-title":"Nature"},{"key":"1414_CR16","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nature03482","volume":"434","author":"J Bartkova","year":"2005","unstructured":"Bartkova, J. et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434, 864\u2013870 (2005).","journal-title":"Nature"},{"key":"1414_CR17","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1093\/jnci\/89.18.1366","volume":"89","author":"II Wistuba","year":"1997","unstructured":"Wistuba, I. I. et al. Molecular damage in the bronchial epithelium of current and former smokers. J. Natl. Cancer Inst. 89, 1366\u20131373 (1997).","journal-title":"J. Natl. Cancer Inst."},{"key":"1414_CR18","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1093\/jnci\/89.12.857","volume":"89","author":"L Mao","year":"1997","unstructured":"Mao, L. et al. Clonal genetic alterations in the lungs of current and former smokers. J. Natl. Cancer Inst. 89, 857\u2013862 (1997).","journal-title":"J. Natl. Cancer Inst."},{"key":"1414_CR19","first-page":"5032","volume":"58","author":"G Sozzi","year":"1998","unstructured":"Sozzi, G. et al. Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Cancer Res. 58, 5032\u20135037 (1998).","journal-title":"Cancer Res."},{"key":"1414_CR20","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1440-1827.2005.01855.x","volume":"55","author":"G Guler","year":"2005","unstructured":"Guler, G. et al. Concordant loss of fragile gene expression early in breast cancer development. Pathol. Int. 55, 471\u2013478 (2005).","journal-title":"Pathol. Int."},{"key":"1414_CR21","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/mc.20122","volume":"44","author":"E Thavathiru","year":"2005","unstructured":"Thavathiru, E., Ludes-Meyers, J. H., MacLeod, M. C. & Aldaz, C. M. Expression of common chromosomal fragile site genes, WWOX\/FRA16D and FHIT\/FRA3B is downregulated by exposure to environmental carcinogens, UV, and BPDE but not by IR. Mol. Carcinog. 44, 174\u2013182 (2005).","journal-title":"Mol. Carcinog."},{"key":"1414_CR22","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1038\/sj.bjc.6602058","volume":"91","author":"M Ottey","year":"2004","unstructured":"Ottey, M. et al. Fhit-deficient normal and cancer cells are mitomycin C and UVC resistant. Br. J. Cancer 91, 1669\u20131677 (2004).","journal-title":"Br. J. Cancer"},{"key":"1414_CR23","doi-asserted-by":"publisher","first-page":"11287","DOI":"10.1158\/0008-5472.CAN-06-2503","volume":"66","author":"H Ishii","year":"2006","unstructured":"Ishii, H. et al. Fhit modulates the DNA damage checkpoint response. Cancer Res. 66, 11287\u201311292 (2006).","journal-title":"Cancer Res."},{"key":"1414_CR24","doi-asserted-by":"publisher","first-page":"e78610","DOI":"10.1371\/journal.pone.0078610","volume":"8","author":"E Gaudio","year":"2013","unstructured":"Gaudio, E. et al. Fhit delocalizes annexin a4 from plasma membrane to cytosol and sensitizes lung cancer cells to paclitaxel. PLoS. One. 8, e78610 (2013).","journal-title":"PLoS. One."},{"key":"1414_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1582-4934.2005.tb00336.x","volume":"9","author":"S Gupta","year":"2005","unstructured":"Gupta, S. & Knowlton, A. A. HSP60, Bax, apoptosis and the heart. J. Cell. Mol. Med. 9, 51\u201358 (2005).","journal-title":"J. Cell. Mol. Med."},{"key":"1414_CR26","doi-asserted-by":"publisher","first-page":"12753","DOI":"10.1073\/pnas.0906484106","volume":"106","author":"A Rimessi","year":"2009","unstructured":"Rimessi, A. et al. Intramitochondrial calcium regulation by the FHIT gene product sensitizes to apoptosis. Proc. Natl. Acad. Sci. USA 106, 12753\u201312758 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1414_CR27","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.bbagrm.2017.01.005","volume":"1860","author":"DL Kiss","year":"2017","unstructured":"Kiss, D. L. et al. Identification of Fhit as a post-transcriptional effector of Thymidine Kinase 1 expression. Biochim Biophys. Acta Gene Regul. Mech. 1860, 374\u2013382 (2017).","journal-title":"Biochim Biophys. Acta Gene Regul. Mech."},{"key":"1414_CR28","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1007\/s00280-006-0217-6","volume":"58","author":"W Ichikawa","year":"2006","unstructured":"Ichikawa, W. et al. Gene expression of ferredoxin reductase predicts outcome in patients with metastatic colorectal cancer treated by 5-fluorouracil plus leucovorin. Cancer Chemother. Pharmacol. 58, 794\u2013801 (2006).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"1414_CR29","unstructured":"Nguyen, D. M. et al. Delivery of the p53 tumor suppressor gene into lung cancer cells by an adenovirus\/DNA complex. Cancer Gene Ther. 4, 191\u2013198 (1997)."},{"key":"1414_CR30","doi-asserted-by":"publisher","first-page":"e2602","DOI":"10.21769\/BioProtoc.2602","volume":"7","author":"R Mendez","year":"2017","unstructured":"Mendez, R. & Banerjee, S. Proximal ligation assay (PLA) on lung tissue and cultured macrophages to demonstrate protein-proteininteraction. . Bio Protoc. 7, e2602 (2017).","journal-title":". Bio Protoc."},{"key":"1414_CR31","first-page":"485","volume":"242","author":"T Kimura","year":"1967","unstructured":"Kimura, T. & Suzuki, K. Components of the electron transport system in adrenal steroid hydroxylase. Isol. Prop. Non-heme iron Protein (adrenodoxin). J. Biol. Chem. 242, 485\u2013491 (1967).","journal-title":"Isol. Prop. Non-heme iron Protein (adrenodoxin). J. Biol. Chem."},{"key":"1414_CR32","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1006\/abbi.1993.1452","volume":"305","author":"I Hanukoglu","year":"1993","unstructured":"Hanukoglu, I., Rapoport, R., Weiner, L. & Sklan, D. Electron leakage from the mitochondrial NADPH-adrenodoxin reductase-adrenodoxin-P450scc (cholesterol side chain cleavage) system. Arch. Biochem. Biophys. 305, 489\u2013498 (1993).","journal-title":"Arch. Biochem. Biophys."},{"key":"1414_CR33","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/nm1001-1111","volume":"7","author":"PM Hwang","year":"2001","unstructured":"Hwang, P. M. et al. Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells. Nat. Med. 7, 1111\u20131117 (2001).","journal-title":"Nat. Med."},{"key":"1414_CR34","doi-asserted-by":"crossref","unstructured":"Liu, G. & Chen, X. The ferredoxin reductase gene is regulated by the p53 family and sensitizes cells to oxidative stress-induced apoptosis. Oncogene 21, 7195\u20137204 (2002).","DOI":"10.1038\/sj.onc.1205862"},{"key":"1414_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0092-8674(04)00046-7","volume":"116","author":"NN Danial","year":"2004","unstructured":"Danial, N. N. & Korsmeyer, S. J. Cell death: critical control points. Cell 116, 205\u2013219 (2004).","journal-title":"Cell"},{"key":"1414_CR36","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00418-003-0566-8","volume":"120","author":"G Diaz","year":"2003","unstructured":"Diaz, G., Liu, S., Isola, R., Diana, A. & Falchi, A. M. Mitochondrial localization of reactive oxygen species by dihydrofluorescein probes. Histochem. Cell. Biol. 120, 319\u2013325 (2003).","journal-title":"Histochem. Cell. Biol."},{"key":"1414_CR37","doi-asserted-by":"publisher","first-page":"34084","DOI":"10.18632\/oncotarget.9122","volume":"7","author":"M Fiorillo","year":"2016","unstructured":"Fiorillo, M. et al. Repurposing atovaquone: targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells. Oncotarget 7, 34084\u201334099 (2016).","journal-title":"Oncotarget"},{"key":"1414_CR38","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41591-018-0052-4","volume":"24","author":"JR Molina","year":"2018","unstructured":"Molina, J. R. et al. An inhibitor of oxidative phosphorylation exploits cancer vulnerability. Nat. Med. 24, 1036\u20131046 (2018).","journal-title":"Nat. Med."},{"key":"1414_CR39","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature13110","volume":"508","author":"K Birsoy","year":"2014","unstructured":"Birsoy, K. et al. Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides. Nature 508, 108\u2013112 (2014).","journal-title":"Nature"},{"key":"1414_CR40","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1042\/bj3520443","volume":"352","author":"Y Shi","year":"2000","unstructured":"Shi, Y., Zou, M., Farid, N. R. & Paterson, M. C. Association of FHIT (fragile histidine triad), a candidate tumour suppressor gene, with the ubiquitin-conjugating enzyme hUBC9. Biochem. J. 352, 443\u2013448 (2000).","journal-title":"Biochem. J."},{"key":"1414_CR41","doi-asserted-by":"publisher","first-page":"24378","DOI":"10.1074\/jbc.274.34.24378","volume":"274","author":"AR Chaudhuri","year":"1999","unstructured":"Chaudhuri, A. R. et al. The tumor suppressor protein Fhit. A novel interaction with tubulin. J. Biol. Chem. 274, 24378\u201324382 (1999).","journal-title":"J. Biol. Chem."},{"key":"1414_CR42","doi-asserted-by":"publisher","first-page":"5745","DOI":"10.1158\/0008-5472.CAN-04-0195","volume":"64","author":"M Nishizaki","year":"2004","unstructured":"Nishizaki, M. et al. Synergistic tumor suppression by coexpression of FHIT and p53 coincides with FHIT-mediated MDM2 inactivation and p53 stabilization in human non-small cell lung cancer cells. Cancer Res. 64, 5745\u20135752 (2004).","journal-title":"Cancer Res."},{"key":"1414_CR43","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1146\/annurev.bi.62.070193.002025","volume":"62","author":"JP Hendrick","year":"1993","unstructured":"Hendrick, J. P. & Hartl, F. U. Molecular chaperone functions of heat-shock proteins. Annu. Rev. Biochem. 62, 349\u2013384 (1993).","journal-title":"Annu. Rev. Biochem."},{"key":"1414_CR44","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3389\/fendo.2016.00106","volume":"7","author":"A Midzak","year":"2016","unstructured":"Midzak, A. & Papadopoulos, V. Adrenal mitochondria and steroidogenesis: from individual proteins to functional protein assemblies. Front Endocrinol. (Lausanne) 7, 106 (2016).","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"1414_CR45","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/j.1349-7006.2009.01168.x","volume":"100","author":"H Okumura","year":"2009","unstructured":"Okumura, H. et al. Fragile gene product, Fhit, in oxidative and replicative stress responses. Cancer Sci. 100, 1145\u20131150 (2009).","journal-title":"Cancer Sci."},{"key":"1414_CR46","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.4161\/15384101.2014.946858","volume":"13","author":"JA Boylston","year":"2014","unstructured":"Boylston, J. A. & Brenner, C. A knockdown with smoke model reveals FHIT as a repressor of Heme oxygenase 1. Cell Cycle 13, 2913\u20132930 (2014).","journal-title":"Cell Cycle"},{"key":"1414_CR47","doi-asserted-by":"publisher","first-page":"e1003077","DOI":"10.1371\/journal.pgen.1003077","volume":"8","author":"JC Saldivar","year":"2012","unstructured":"Saldivar, J. C. et al. Initiation of genome instability and preneoplastic processes through loss of Fhit expression. PLoS. Genet. 8, e1003077 (2012).","journal-title":"PLoS. Genet."},{"key":"1414_CR48","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/cncr.20137","volume":"100","author":"G Guler","year":"2004","unstructured":"Guler, G. et al. The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma. Cancer 100, 1605\u20131614 (2004).","journal-title":"Cancer"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1414-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1414-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1414-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T11:32:27Z","timestamp":1671190347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1414-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,15]]},"references-count":48,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3]]}},"alternative-id":["1414"],"URL":"https:\/\/doi.org\/10.1038\/s41419-019-1414-7","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,15]]},"assertion":[{"value":"30 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"147"}}